期刊文献+

头颈部腺样囊性癌及癌旁组织中mir-21的表达 被引量:1

Expression of mir-21 in adenoid cystic carcinoma of head and neck and its clinical significance
下载PDF
导出
摘要 目的通过检测头颈部腺样囊性癌(HNACC)及癌旁组织中mir-21的相对表达量,分析其与HNACC临床病理特征的关系。方法采用实时荧光定量PCR技术检测36例HNACC组织和19例癌旁组织中mir-21的表达量。结果 mir-21在ACC组织中的表达量明显高于癌旁组织,差异有统计学意义(P<0.01);转移复发组的mir-21表达量高于非转移复发组,差异有统计学意义(P<0.05);不同年龄、性别、神经累及、骨累及以及不同TNM分期的mir-21的表达量的差异均无统计学意义(均P>0.05)。结论mir-21的高表达与HNACC的发生、发展可能存在密切联系,且在其复发和转移中可能发挥着一定的作用。 Objective To investigate the expression of mir- 21 in adenoid cystic carcinoma of head and neck (HNACC) and its clinical significance. Methods The expression of miR- 21 was detected by real- time fluorescence quantitative PCR in 36 samples of HNACC tissue and 19 samples of para- carcinoma tissue. Results The expression of mir- 21 was significantly higher in HNACC tissues compared to para- carcinoma tissues (P&lt;0.01). The expression of mir- 21 of metastasis and/or recurrence group significantly higher than non- metastasis and recurrence group (P&lt;0.05). Conclusion Results indicate that high expres-sion of mir- 21 may be related to the development of HNACC, and it may also be involved in the metastasis and recurrence of HNACC.
出处 《浙江医学》 CAS 2014年第7期550-552,共3页 Zhejiang Medical Journal
基金 浙江省医药卫生平台重点资助计划(2012ZDA005) 浙江省卫生高层次创新人才培养工程基金资助[浙卫发2008(134)]
关键词 头颈腺样囊性癌 微小RNA- 21 MicroRNA- 21 实时荧光定量PCR Adenoid cystic carcinoma of head and neck Real- time fluorescence quantitative PCR
  • 相关文献

参考文献11

  • 1Liu J, Shao C, Tan M L, et al. Molecular biology of adenoid cystic carcinoma [J]. Head Neck, 2012, 34(11): 1665-1677.
  • 2Schramedei K, Morbt N, Pfeifer G, et al. MicroRNA-21 targets tu- mor suppressor genes ANP32A and SMARCA4[J]. Oncogene, 2011, 30(26): 2975-2985.
  • 3John K, Wu J, Lee B W, et al. MicroRNAs in Head and Neck Cancer[J]. Int J Dent, 2013, 65:218.
  • 4Zhang J X, Song W, Chert Z H, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis[J]. Lancet Oncol, 2013, 14(13): 1295-1306.
  • 5Li B, Ren S, Li X, et al. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer [J]. Lung Cancer, 2013, 83(2):146-153.
  • 6Lehmann U, Streichert T, Otto B, et al. Identification of differentially expressed microRNAs in human male breast cancer [J]. BMC Cancer, 2010, 10:109.
  • 7Cao Z, Yoon J H, Nam S W, et al. PDCD4 expression inversely correlated with miR-21 levels in gastric cancers [J]. J Cancer Res Clin Oncol, 2012, 138(4): 611-619.
  • 8Yan-Nan B, Zhao-Yan Y, Li-Xi L, et al. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN [J]. Biochem Biophys Res Commun, 2013,443(3):802-807.
  • 9Lawrie C H, Gal S, Dunlop H M, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol, 2008, 141(5): 672-675.
  • 10Yang M, Shen H, Qiu C, et al. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer[J]. EurJ Cancer, 2013, 49(3): 604-615.

同被引文献16

  • 1杨文涛,张廷璆,沈铭昌,袁亚.乳腺腺样囊性癌临床病理特点及文献复习[J].临床与实验病理学杂志,2005,21(1):10-13. 被引量:28
  • 2乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.231-232.265-266.
  • 3Law YM, Quek ST, Tan PH, et al. Adenoid cystic carcinoma of the breast[J]. Singapore Med J, 2009,50(1) :eS-ell.
  • 4Canyilmaz E, Uslu GH, Memit Y, et al. Adenoid cystic carcinoma of the breast A case report and literature review[J]. Oncol Lett,2014,7(5) 1599- 1601.
  • 5Thompson K, Grabowski J, Sahzstein SL, et al, Adenoid cystic breast carcinoma is axillary staging necessary in all cases? Re- suits from the California Cancer Registry. Breast J, 2011,17 (5) .485-489.
  • 6赵兴娟,高润芳,杨璇.实体型腺样囊性乳腺癌临床病例特点及其诊治的分析[J].医学信息,2013.26(7):106.
  • 7Ghabach B, Anderson WF, Curtis RE, et al. Adenoid cystic carcinoma of the breast in the United States( 1977 to 2006):a population based cohort study[J]. Breast Cancer Res, 2010,12 (4) :R54.
  • 8徐东波,孙保存,张利华.腺样囊性癌组织神经生长因子及受体表达与神经浸润相关性的探讨[J].中华肿瘤防治杂志,2011,18(14):1110-1113. 被引量:2
  • 9洪勇.三阴性乳腺癌研究进展[J].中国肿瘤临床与康复,2012,19(1):92-93. 被引量:16
  • 10肖宇,李惠平,雷玉涛,赵红梅,王晶.178例三阴性乳腺癌的临床病理特征及生存分析[J].肿瘤防治研究,2012,39(4):412-416. 被引量:2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部